Loxo Oncology has been granted a patent for compounds used in treating systemic sclerosis, fibrosis, achondroplasia, thanatophoric dysplasia, SADDAN, muenke syndrome, and cancer. GlobalData’s report on Loxo Oncology gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Loxo Oncology, was a key innovation area identified from patents.
A recently granted patent (Publication Number: US11878976B2) discloses a compound of a specific formula, along with various derivatives and pharmaceutically acceptable salts. The compound is designed for potential use in pharmaceutical compositions aimed at treating cancer. The patent claims cover different variations of the compound, including specific configurations of X, R, Z, Y, and other substituents, highlighting the versatility and potential applications of the disclosed compound in cancer treatment.
Moreover, the patent also includes claims related to a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier, diluent, or excipient. Additionally, a method of treating cancer is outlined, involving the administration of the compound or its salt to patients in need of such treatment. The method specifically targets various types of cancer, including breast cancer, lung cancer, bladder cancer, urothelial cancer, pancreatic cancer, melanoma, and others, showcasing the broad spectrum of potential applications for the disclosed compound in combating different forms of cancer, including FGFR3-associated cancer. Overall, the patent provides a comprehensive overview of the compound's structure, derivatives, and its potential role in cancer treatment, paving the way for further research and development in the field of oncology.
To know more about GlobalData’s detailed insights on Loxo Oncology, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
